Significant associations seen for high blood pressure, diabetes, and stroke. HealthDay News — Microplastic exposure may increase the risk for chronic diseases, according to a study presented at the ...

A San Diego-based biotech company focused on advancing cell, gene, and mRNA-based therapies. Artis emerged from stealth in April 2025 with the acquisition of Landmark Bio, a prominent cell and gene ...

In addition to COPD, Dupixent is approved in Japan in certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic spontaneous ...

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Artists take on the clown signal, baby steps, and more From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning ...

Dupixent® has been characterized as a critical growth driver for the company, with strong potential for further expansion. The drug’s efficacy throughout multiple inflammatory conditions as ...

Amid the smoke, water cannons, and chaos of Turkey's mass protests, a flash of yellow darted through the streets of Antalya. It wasn't a protest banner or a flare - it was Pikachu. A protester ...

The Independent has contacted the studio for comment. It follows news that HBO Max scrubbed the iconic cartoon’s original shorts from the streaming site. The streaming site, which is owned by ...

The coffee chain has a new collab with an iconic cartoon (Picture: Artur Widak/NurPhoto via Getty Images) Starbucks fans are in for a special treat over the coming weeks, as the drinks chain has ...

Review-Journal editorial cartoonist Michael Ramirez is a two-time winner of the Pulitzer Prize and a four-time winner of the Sigma Delta Chi Award.

In addition to COPD, Dupixent is approved in Japan in certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic ...